APPLE TREE PARTNERS II LP

CIK 00011437892 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001143789

Recent Transactions

31 trades

Other
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-07-06−1,380,241→ 0 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-26$5.45/sh−10,528→ 1,380,241 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-25$5.86/sh−913→ 1,390,769 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-22$5.98/sh−94,816→ 1,391,682 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-21$5.30/sh−1,447→ 1,486,498 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-20$5.30/sh−5,200→ 1,487,945 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-19$5.30/sh−139→ 1,493,145 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-18$5.35/sh−1,432→ 1,493,284 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-15$5.32/sh−7,961→ 1,494,716 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-12$5.40/sh−10,843→ 1,502,677 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-11$5.41/sh−18,525→ 1,513,520 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-08$5.40/sh−9,617→ 1,532,045 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-06-07$5.47/sh−20→ 1,541,662 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-04-19$6.29/sh−104,799→ 1,541,682 total
Sale
Rein Therapeutics, Inc.$RNTX
Common Stock
2018-04-17$7.05/sh−3,105→ 1,646,481 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+18,771→ 19,022 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+1,780,564→ 1,799,586 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series C-2 Preferred Stock
2017-07-05−4,238,607→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series A Preferred Stock
2017-07-05−1,250,000→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series A-1 Preferred Stock
2017-07-05−615,384→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series B Preferred Stock
2017-07-05−3,706,056→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series C-1 Preferred Stock
2017-07-05−2,967,025→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series D Preferred Stock
2017-07-05−6,781,770→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series D-1 Preferred Stock
2014-09-22−8,711,335→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series C Preferred Stock
2014-09-22−14,604,833→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series D-2 Preferred Stock
2014-09-22−1,539,643→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series D-3 Preferred Stock
2014-09-22−13,370,422→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series A Preferred Stock
2014-09-22−4,500,000→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series B-1 Preferred Stock
2014-09-22−798,067→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Series B-2 Preferred Stock
2014-09-22−644,786→ 0 total
Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Common Stock
2014-09-22+4,218,632→ 4,218,641 total

Companies

Recent Filings

Address

47 HULFISH STREET SUITE 441

PRINCETON, NJ, 08542

View on SEC.gov